• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
High-Level Pan-Azole-Resistant Aspergillosis.高水平泛唑耐药曲霉病
J Clin Microbiol. 2015 Jul;53(7):2343-5. doi: 10.1128/JCM.00502-15. Epub 2015 Apr 22.
2
High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance.在唑类药物耐药率较低的单家医院环境中,慢性肺部曲霉病患者在使用唑类抗真菌药物治疗后,烟曲霉对唑类药物耐药的检出率较高。
Med Mycol. 2021 Apr 6;59(4):327-334. doi: 10.1093/mmy/myaa052.
3
New case of azole-resistant Aspergillus fumigatus due to TR46/Y121F/T289A mutation in Belgium.比利时出现因TR46/Y121F/T289A突变导致的对唑类耐药的烟曲霉新病例。
J Antimicrob Chemother. 2014 Dec;69(12):3439-40. doi: 10.1093/jac/dku289. Epub 2014 Aug 1.
4
Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany.德国造血干细胞移植受者中出现对唑类耐药的侵袭性曲霉病。
J Antimicrob Chemother. 2015 May;70(5):1522-6. doi: 10.1093/jac/dku566. Epub 2015 Jan 27.
5
Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.烟曲霉唑类抗药性:2008 年和 2009 年。
J Antimicrob Chemother. 2010 Oct;65(10):2116-8. doi: 10.1093/jac/dkq279. Epub 2010 Aug 20.
6
First isolation of the pan-azole-resistant Aspergillus fumigatus cyp51A TR46/Y121F/T289A mutant in a UK patient.在一名英国患者中首次分离出泛唑耐药烟曲霉cyp51A TR46/Y121F/T289A突变体。
Int J Antimicrob Agents. 2017 Apr;49(4):512-514. doi: 10.1016/j.ijantimicag.2017.01.004. Epub 2017 Feb 9.
7
High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients.高危患者烟曲霉分离株中唑类耐药的高流行率。
J Antimicrob Chemother. 2015 Oct;70(10):2894-8. doi: 10.1093/jac/dkv177. Epub 2015 Jul 9.
8
Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India.在印度从携带 cyp51A 基因 TR/L98H 突变的多唑耐药烟曲霉分离株。
J Antimicrob Chemother. 2012 Feb;67(2):362-6. doi: 10.1093/jac/dkr443. Epub 2011 Oct 25.
9
Azole resistance among clinical isolates of Aspergillus fumigatus in Lima-Peru.秘鲁利马地区烟曲霉临床分离株的唑类耐药性。
Med Mycol. 2020 Jan 1;58(1):54-60. doi: 10.1093/mmy/myz032.
10
Azole-resistant Aspergillus fumigatus isolates carrying TR₃₄/L98H mutations in Taiwan.台湾地区携带TR₃₄/L98H突变的耐唑类烟曲霉分离株
Mycoses. 2015 Sep;58(9):544-9. doi: 10.1111/myc.12354. Epub 2015 Jul 27.

引用本文的文献

1
Insights into Colonization in Cystic Fibrosis and Cross-Transmission between Patients and Hospital Environments.囊性纤维化中的定植以及患者与医院环境之间交叉传播的见解
J Fungi (Basel). 2024 Jun 29;10(7):461. doi: 10.3390/jof10070461.
2
Epidemiology and Antifungal Susceptibility Patterns of Invasive Fungal Infections (IFIs) in India: A Prospective Observational Study.印度侵袭性真菌感染(IFI)的流行病学及抗真菌药敏模式:一项前瞻性观察研究
J Fungi (Basel). 2021 Dec 30;8(1):33. doi: 10.3390/jof8010033.
3
Future challenges and chances in the diagnosis and management of invasive mould infections in cancer patients.癌症患者侵袭性霉菌感染的诊断和管理的未来挑战和机遇。
Med Mycol. 2021 Jan 4;59(1):93-101. doi: 10.1093/mmy/myaa079.
4
Azole-resistant Aspergillus and Echinocandin-resistant Candida - What are the treatment options?耐唑类曲霉菌和耐棘白菌素念珠菌——治疗选择有哪些?
Curr Fungal Infect Rep. 2020 Jun;14(2):141-152. doi: 10.1007/s12281-020-00379-2. Epub 2020 Mar 26.
5
Mutations, Extrolite Profiles, and Antifungal Susceptibility in Clinical and Environmental Isolates of the Aspergillus viridinutans Species Complex.变异性、外生代谢产物谱和临床及环境曲霉属绿僵菌种复合体分离株的抗真菌药敏性。
Antimicrob Agents Chemother. 2019 Oct 22;63(11). doi: 10.1128/AAC.00632-19. Print 2019 Nov.
6
Emergence of Azole-Resistant Aspergillus fumigatus from Immunocompromised Hosts in India.印度免疫功能低下宿主中唑类耐药烟曲霉的出现。
Antimicrob Agents Chemother. 2018 Jul 27;62(8). doi: 10.1128/AAC.02264-17. Print 2018 Aug.
7
Comparison of Two Molecular Assays for Detection and Characterization of Triazole Resistance and Mutations in Clinical Isolates and Primary Clinical Samples of Immunocompromised Patients.两种分子检测方法用于检测和鉴定免疫功能低下患者临床分离株及原代临床样本中三唑耐药性和突变的比较
Front Microbiol. 2018 Mar 27;9:555. doi: 10.3389/fmicb.2018.00555. eCollection 2018.
8
Chronic Pulmonary Aspergillosis-Where Are We? and Where Are We Going?慢性肺曲霉病——我们现在何处?又将走向何方?
J Fungi (Basel). 2016 Jun 7;2(2):18. doi: 10.3390/jof2020018.
9
Emergence of Echinocandin Resistance Due to a Point Mutation in the Gene of Aspergillus fumigatus in a Patient with Chronic Pulmonary Aspergillosis.烟曲霉基因点突变导致慢性肺部曲霉病患者出现棘白菌素类耐药。
Antimicrob Agents Chemother. 2017 Nov 22;61(12). doi: 10.1128/AAC.01277-17. Print 2017 Dec.
10
Molecular Tools for the Detection and Deduction of Azole Antifungal Drug Resistance Phenotypes in Aspergillus Species.用于检测和推断曲霉属物种中唑类抗真菌药物耐药表型的分子工具
Clin Microbiol Rev. 2017 Oct;30(4):1065-1091. doi: 10.1128/CMR.00095-16.

本文引用的文献

1
Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands.荷兰野生型、TR34/L98H 和 TR46/Y121F/T289A 烟曲霉分离株的唑类、多烯和棘白菌素 MIC 分布。
J Antimicrob Chemother. 2015 Jan;70(1):178-81. doi: 10.1093/jac/dku364. Epub 2014 Oct 9.
2
The role of azoles in the management of azole-resistant aspergillosis: from the bench to the bedside.唑类药物在耐唑类曲霉病管理中的作用:从实验室到临床。
Drug Resist Updat. 2014 Jul;17(3):37-50. doi: 10.1016/j.drup.2014.06.001. Epub 2014 Jul 5.
3
Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.抗真菌药物的折点:EUCAST 关于棘白菌素类抗念珠菌和三唑类抗曲霉的更新
Drug Resist Updat. 2013 Dec;16(6):81-95. doi: 10.1016/j.drup.2014.01.001. Epub 2014 Jan 27.
4
Azole resistance in Aspergillus fumigatus: a growing public health concern.烟曲霉唑类耐药性:日益严重的公共卫生问题。
Curr Opin Infect Dis. 2013 Dec;26(6):493-500. doi: 10.1097/QCO.0000000000000005.
5
In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole.烟曲霉对伊曲康唑、伏立康唑和泊沙康唑的体外药敏性:与伏立康唑的相关性。
Antimicrob Agents Chemother. 2013 Nov;57(11):5778-80. doi: 10.1128/AAC.01141-13. Epub 2013 Sep 16.
6
Impact of in vivo triazole and echinocandin combination therapy for invasive pulmonary aspergillosis: enhanced efficacy against Cyp51 mutant isolates.体内三唑类药物和棘白菌素联合治疗侵袭性肺曲霉病:增强对 Cyp51 突变株的疗效。
Antimicrob Agents Chemother. 2013 Nov;57(11):5438-47. doi: 10.1128/AAC.00833-13. Epub 2013 Aug 19.
7
Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.烟曲霉所致伏立康唑高度耐药性曲霉菌感染及耐药相关分离株在家庭环境中的重现。
Clin Infect Dis. 2013 Aug;57(4):513-20. doi: 10.1093/cid/cit320. Epub 2013 May 10.
8
The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus.cdr1B 外排转运蛋白与烟曲霉中非 Cyp51a 介导的伊曲康唑耐药性相关。
J Antimicrob Chemother. 2013 Jul;68(7):1486-96. doi: 10.1093/jac/dkt075. Epub 2013 Apr 10.
9
Pharmacodynamics and dose-response relationships of liposomal amphotericin B against different azole-resistant Aspergillus fumigatus isolates in a murine model of disseminated aspergillosis.脂质体两性霉素 B 对不同唑类耐药烟曲霉分离株在播散性曲霉病小鼠模型中的药效学和剂量反应关系。
Antimicrob Agents Chemother. 2013 Apr;57(4):1866-71. doi: 10.1128/AAC.02226-12. Epub 2013 Feb 4.
10
High-level expression of cyp51B in azole-resistant clinical Aspergillus fumigatus isolates.唑类耐药临床烟曲霉分离株中 CYP51B 的高水平表达。
J Antimicrob Chemother. 2013 Mar;68(3):512-4. doi: 10.1093/jac/dks451. Epub 2012 Dec 2.

高水平泛唑耐药曲霉病

High-Level Pan-Azole-Resistant Aspergillosis.

作者信息

van Ingen Jakko, van der Lee Henrich A L, Rijs Antonius J M M, Snelders Eveline, Melchers Willem J G, Verweij Paul E

机构信息

Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands.

Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands

出版信息

J Clin Microbiol. 2015 Jul;53(7):2343-5. doi: 10.1128/JCM.00502-15. Epub 2015 Apr 22.

DOI:10.1128/JCM.00502-15
PMID:25903576
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4473200/
Abstract

High-level pan-azole-resistant Aspergillus fumigatus was recovered from four patients with chronic lung disease. In one patient, the development of progressive resistance followed long-term azole therapy and switching between antifungal azoles. The high-level pan-azole-resistant phenotypes were not associated with a specific cyp51A gene mutation. New strategies that avoid the development of progressive azole resistance are needed.

摘要

从4例慢性肺病患者中分离出了对泛唑类高度耐药的烟曲霉。在1例患者中,长期唑类治疗以及在抗真菌唑类之间换药后出现了逐步耐药的情况。高度泛唑耐药表型与特定的cyp51A基因突变无关。需要采取避免逐步产生唑类耐药的新策略。